Skip to main content
Top
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Commentary

Big data and data repurposing - using existing data to answer new questions in vascular dementia research

Authors: Fergus N. Doubal, Myzoon Ali, G. David Batty, Andreas Charidimou, Maria Eriksdotter, Martin Hofmann-Apitius, Yun-Hee Kim, Deborah A. Levine, Gillian Mead, Hermann A. M. Mucke, Craig W. Ritchie, Charlotte J. Roberts, Tom C. Russ, Robert Stewart, William Whiteley, Terence J. Quinn

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Introduction

Traditional approaches to clinical research have, as yet, failed to provide effective treatments for vascular dementia (VaD). Novel approaches to collation and synthesis of data may allow for time and cost efficient hypothesis generating and testing. These approaches may have particular utility in helping us understand and treat a complex condition such as VaD.

Methods

We present an overview of new uses for existing data to progress VaD research. The overview is the result of consultation with various stakeholders, focused literature review and learning from the group’s experience of successful approaches to data repurposing. In particular, we benefitted from the expert discussion and input of delegates at the 9th International Congress on Vascular Dementia (Ljubljana, 16-18th October 2015).

Results

We agreed on key areas that could be of relevance to VaD research: systematic review of existing studies; individual patient level analyses of existing trials and cohorts and linking electronic health record data to other datasets. We illustrated each theme with a case-study of an existing project that has utilised this approach.

Conclusions

There are many opportunities for the VaD research community to make better use of existing data. The volume of potentially available data is increasing and the opportunities for using these resources to progress the VaD research agenda are exciting. Of course, these approaches come with inherent limitations and biases, as bigger datasets are not necessarily better datasets and maintaining rigour and critical analysis will be key to optimising data use.
Literature
1.
2.
go back to reference Ritchie CW, Muniz Terrera G, Quinn TJ. Dementia trials an dementia tribulations: methodological and analytical challenges in dementia research. Alzheimer Res Therpay. 2015;7:31.CrossRef Ritchie CW, Muniz Terrera G, Quinn TJ. Dementia trials an dementia tribulations: methodological and analytical challenges in dementia research. Alzheimer Res Therpay. 2015;7:31.CrossRef
3.
go back to reference Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R. Increasing value and reducing waste in research design, conduct and analysis. Lancet. 2014;383:166–75.CrossRefPubMedPubMedCentral Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R. Increasing value and reducing waste in research design, conduct and analysis. Lancet. 2014;383:166–75.CrossRefPubMedPubMedCentral
4.
go back to reference Deetjen U, Meyer ET, Schroeder R. “Big Data for Advancing Dementia Research: An Evaluation of Data Sharing Practices in Research on Age-related Neurodegenerative Diseases”, OECD Digital Economy Papers, No. 246, 2015 OECD Publishing, Paris. doi: http://dx.doi.org/10.1787/5js4sbddf7jk-en Deetjen U, Meyer ET, Schroeder R. “Big Data for Advancing Dementia Research: An Evaluation of Data Sharing Practices in Research on Age-related Neurodegenerative Diseases”, OECD Digital Economy Papers, No. 246, 2015 OECD Publishing, Paris. doi: http://​dx.​doi.​org/​10.​1787/​5js4sbddf7jk-en
5.
go back to reference Catlett NL, Bargnesi AJ, Ungerer S, Seagaran T, Ladd W, Elliston KO, Prat D. Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC Bioinformatics. 2013;14:340.CrossRefPubMedPubMedCentral Catlett NL, Bargnesi AJ, Ungerer S, Seagaran T, Ladd W, Elliston KO, Prat D. Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC Bioinformatics. 2013;14:340.CrossRefPubMedPubMedCentral
6.
go back to reference Mucke HA. Focus, medicinal chemistry, informatics: towards the pharmaceutical patentome. Pharm Pat Anal. 2012;1:229–31.CrossRefPubMed Mucke HA. Focus, medicinal chemistry, informatics: towards the pharmaceutical patentome. Pharm Pat Anal. 2012;1:229–31.CrossRefPubMed
7.
go back to reference Jang D, Lee S, Lee J, Kim K, Lee D. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects. J Biomed Inform. 2016;49:248–57.CrossRef Jang D, Lee S, Lee J, Kim K, Lee D. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects. J Biomed Inform. 2016;49:248–57.CrossRef
8.
go back to reference Xu R, Wang Q. Comparing a knowledge-driven approach to a supervised machine learning approach in large-scale extraction of drug-side effect relationships from free-text biomedical literature. BMC Bioinformatics. 2015;16 Suppl 5:S6.CrossRefPubMedPubMedCentral Xu R, Wang Q. Comparing a knowledge-driven approach to a supervised machine learning approach in large-scale extraction of drug-side effect relationships from free-text biomedical literature. BMC Bioinformatics. 2015;16 Suppl 5:S6.CrossRefPubMedPubMedCentral
9.
go back to reference Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JPA, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.CrossRefPubMed Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JPA, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.CrossRefPubMed
10.
go back to reference McCann SK, Irvine C, Mead GE, Sena ES, Currie GL, Egan KE, Macleod MR, Howells DW. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. Stroke. 2014;45:3055–63.CrossRefPubMed McCann SK, Irvine C, Mead GE, Sena ES, Currie GL, Egan KE, Macleod MR, Howells DW. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. Stroke. 2014;45:3055–63.CrossRefPubMed
11.
go back to reference Mead GE, Hsieh C-F, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286. doi:10.1002/14651858.CD009286.PubMed Mead GE, Hsieh C-F, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286. doi:10.​1002/​14651858.​CD009286.PubMed
12.
go back to reference Mead G, Hackett ML, Lundström E, Murray V, Hankey GJ, Dennis M. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials. Trials. 2015;16:369. doi:10.1186/s13063-015-0864-1.CrossRefPubMedPubMedCentral Mead G, Hackett ML, Lundström E, Murray V, Hankey GJ, Dennis M. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials. Trials. 2015;16:369. doi:10.​1186/​s13063-015-0864-1.CrossRefPubMedPubMedCentral
13.
go back to reference Quinn TJ, Fearon P, Noel-Storr AH, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev. 2014;4:CD010079. Quinn TJ, Fearon P, Noel-Storr AH, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev. 2014;4:CD010079.
14.
go back to reference Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum SJ, Davis D, Quinn TJ, Hyde C, Rutjes AW, Smailagic N, Marcus S, Black S, Blennow K, Brayne C, Fiorivanti M, Johnson JK, Köpke S, Schneider LS, Simmons A, Mattsson N, Zetterberg H, Bossuyt PM, Wilcock G, McShane R. Reporting standards for studies of diagnostic test accuracy in dementia The STARDdem Initiative. Neurology. 2014;83:364–73.CrossRefPubMedPubMedCentral Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum SJ, Davis D, Quinn TJ, Hyde C, Rutjes AW, Smailagic N, Marcus S, Black S, Blennow K, Brayne C, Fiorivanti M, Johnson JK, Köpke S, Schneider LS, Simmons A, Mattsson N, Zetterberg H, Bossuyt PM, Wilcock G, McShane R. Reporting standards for studies of diagnostic test accuracy in dementia The STARDdem Initiative. Neurology. 2014;83:364–73.CrossRefPubMedPubMedCentral
15.
go back to reference Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C, Brayne C, McShane R, Cullum S. Neuropsychological tests for the diagnosis of Alzheimer’s Disease dementia and other dementias: a generic protocol for cross-sectional and delayed verification studies. Cochrane Database Syst Rev 2013:3:CD010460. doi:10.1002/14651858.CD010460. Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C, Brayne C, McShane R, Cullum S. Neuropsychological tests for the diagnosis of Alzheimer’s Disease dementia and other dementias: a generic protocol for cross-sectional and delayed verification studies. Cochrane Database Syst Rev 2013:3:CD010460. doi:10.​1002/​14651858.​CD010460.
16.
go back to reference Rands G, Orrell M. Aspirin for vascular dementia. Cochrane Database Syst Rev. 2000;4:CD001296. Rands G, Orrell M. Aspirin for vascular dementia. Cochrane Database Syst Rev. 2000;4:CD001296.
17.
go back to reference Hoffman T, Bennett S, Koh C, McKenna KT. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2010;4:CD006430. Hoffman T, Bennett S, Koh C, McKenna KT. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2010;4:CD006430.
18.
go back to reference Lees R, Fearon P, Harrison JK, Broomfield NM, Quinn TJ. Cognitive and mood assessment in stroke research: focussed review of contemporary studies. Stroke. 2012;43:1678–80.CrossRefPubMed Lees R, Fearon P, Harrison JK, Broomfield NM, Quinn TJ. Cognitive and mood assessment in stroke research: focussed review of contemporary studies. Stroke. 2012;43:1678–80.CrossRefPubMed
19.
go back to reference Ali M, Bath P, Brady M, Davis S, Diener H-C, Donnan G, Fisher M, Hacke W, Hanley DF, Luby M, Tsivgoulis G, Wahlgren N, Warach S. Lees KR OBotVSC. Development, Expansion and Use of a Stroke Clinical Trials Resource for Novel Exploratory Analyses. Int J Stroke. 2012;7:133–8.CrossRefPubMed Ali M, Bath P, Brady M, Davis S, Diener H-C, Donnan G, Fisher M, Hacke W, Hanley DF, Luby M, Tsivgoulis G, Wahlgren N, Warach S. Lees KR OBotVSC. Development, Expansion and Use of a Stroke Clinical Trials Resource for Novel Exploratory Analyses. Int J Stroke. 2012;7:133–8.CrossRefPubMed
20.
go back to reference Abdul-Rahim A, Fulton RL, Sucharew H, Kleindorfer D, Khatri P, Broderick JP, Lees KR, for the VISTA Collaborators. National Institutes of health stroke scale item profiles as predictor of patient outcome external validation on independent trial data. Stroke. 2015;46:395–400.CrossRefPubMed Abdul-Rahim A, Fulton RL, Sucharew H, Kleindorfer D, Khatri P, Broderick JP, Lees KR, for the VISTA Collaborators. National Institutes of health stroke scale item profiles as predictor of patient outcome external validation on independent trial data. Stroke. 2015;46:395–400.CrossRefPubMed
21.
go back to reference Ovbiagele B, Reeves MJ, Nasiri M, Johnston SC, Bath PM, Saposnik G, for the VISTA-Acute Collaboration Steering Committee. A Simple Risk Index andThrombolytic Treatment Response in Acute Ischemic Stroke. JAMA Neurology 2014;71(7):848–54. doi:10.1001/jamaneurol.2014.689. Ovbiagele B, Reeves MJ, Nasiri M, Johnston SC, Bath PM, Saposnik G, for the VISTA-Acute Collaboration Steering Committee. A Simple Risk Index andThrombolytic Treatment Response in Acute Ischemic Stroke. JAMA Neurology 2014;71(7):848–54. doi:10.​1001/​jamaneurol.​2014.​689.
22.
go back to reference Kerr D, Fulton RL, Lees KR, for the VISTA Collaborators. Day 7 NIHSS is a Sensitive Outcome Measure for Exploratory Clinical Trials in Acute Stroke: Evidence from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2012;43:1401–3.CrossRefPubMed Kerr D, Fulton RL, Lees KR, for the VISTA Collaborators. Day 7 NIHSS is a Sensitive Outcome Measure for Exploratory Clinical Trials in Acute Stroke: Evidence from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2012;43:1401–3.CrossRefPubMed
23.
go back to reference Brainin M, Tuomilehto J, Heiss WD, Bornstein NM, Bath PM, Teuschl Y, Richard E, Guekht A, Quinn T, Post Stroke Cognition Study Group. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol. 2015;22(2):229–38.CrossRefPubMed Brainin M, Tuomilehto J, Heiss WD, Bornstein NM, Bath PM, Teuschl Y, Richard E, Guekht A, Quinn T, Post Stroke Cognition Study Group. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol. 2015;22(2):229–38.CrossRefPubMed
24.
go back to reference Arba F, Quinn TJ, Hankey GJ, Lees KR, Wardlaw JM, Ali M, Inzitari D. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischaemic attack. Int J Stroke. Published online before print August 19, 2016, doi:10.1177/1747493016666091 Arba F, Quinn TJ, Hankey GJ, Lees KR, Wardlaw JM, Ali M, Inzitari D. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischaemic attack. Int J Stroke. Published online before print August 19, 2016, doi:10.​1177/​1747493016666091​
26.
go back to reference Levine DA, Galecki AT, Langa KM, Unverzaqt FW, Kabeto MU, Giordania B, Wadley VG. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314:41–51.CrossRefPubMedPubMedCentral Levine DA, Galecki AT, Langa KM, Unverzaqt FW, Kabeto MU, Giordania B, Wadley VG. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314:41–51.CrossRefPubMedPubMedCentral
27.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;2002(360):1903–13. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;2002(360):1903–13.
28.
go back to reference Danesh J, Erqou S, Walker M, Thompson SG. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22:839–69.CrossRefPubMed Danesh J, Erqou S, Walker M, Thompson SG. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22:839–69.CrossRefPubMed
29.
go back to reference Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.CrossRefPubMedPubMedCentral Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.CrossRefPubMedPubMedCentral
30.
go back to reference Jokela M, Batty GD, Hintsa T, Elovainio M, Hakulinen C, Kivimaki M. Is personality associated with cancer incidence and mortality? An individual-participant meta-analysis of 2156 incident cancer cases among 42,843 men and women. Br J Cancer. 2014;110:1820–4.CrossRefPubMedPubMedCentral Jokela M, Batty GD, Hintsa T, Elovainio M, Hakulinen C, Kivimaki M. Is personality associated with cancer incidence and mortality? An individual-participant meta-analysis of 2156 incident cancer cases among 42,843 men and women. Br J Cancer. 2014;110:1820–4.CrossRefPubMedPubMedCentral
31.
go back to reference Russ TC, Kivimäki M, Starr JM, Stamatakis E, Batty GD. Height in relation to dementia death: individual-participant meta-analysis of eighteen uk prospective cohort studies. Br J Psychiatry. 2014;205:348–54.CrossRefPubMedPubMedCentral Russ TC, Kivimäki M, Starr JM, Stamatakis E, Batty GD. Height in relation to dementia death: individual-participant meta-analysis of eighteen uk prospective cohort studies. Br J Psychiatry. 2014;205:348–54.CrossRefPubMedPubMedCentral
32.
go back to reference Gray L, Batty DG, Craig P, Stewart C, Whyte B, Finlayson A, Leyland AH. Cohort profile: the Scottish health surveys cohort: linkage of study participants to routinely collected records for mortality, hospital discharge, cancer and offspring birth characteristics in three nationwide studies. Int J Epidemiol. 2010;39:345–50.CrossRefPubMedPubMedCentral Gray L, Batty DG, Craig P, Stewart C, Whyte B, Finlayson A, Leyland AH. Cohort profile: the Scottish health surveys cohort: linkage of study participants to routinely collected records for mortality, hospital discharge, cancer and offspring birth characteristics in three nationwide studies. Int J Epidemiol. 2010;39:345–50.CrossRefPubMedPubMedCentral
33.
go back to reference Mindell J, Biddulph JP, Hirani V, Stamatakis E, Craig R, Nunn S, Shelton N. Cohort profile: the health survey for England. Int J Epidemiol. 2012;41:1585–93.CrossRefPubMed Mindell J, Biddulph JP, Hirani V, Stamatakis E, Craig R, Nunn S, Shelton N. Cohort profile: the health survey for England. Int J Epidemiol. 2012;41:1585–93.CrossRefPubMed
35.
go back to reference Perera G, Broadbent M, Callard F, Chang C-K, Downs J, Dutta R, Fernandes A, Hayes RD, Henderson M, Jackson R, Jewell A, Kadra G, Little R, Pritchard M, Shetty H, Tulloch A, Stewart R. Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record derived data resource. BMJ Open. 2016;6:e008721.CrossRefPubMedPubMedCentral Perera G, Broadbent M, Callard F, Chang C-K, Downs J, Dutta R, Fernandes A, Hayes RD, Henderson M, Jackson R, Jewell A, Kadra G, Little R, Pritchard M, Shetty H, Tulloch A, Stewart R. Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record derived data resource. BMJ Open. 2016;6:e008721.CrossRefPubMedPubMedCentral
36.
go back to reference Perera G, Khondoker M, Broadbent M, Breen G, Stewart R. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health case register in London. PLoS ONE. 2014;9:e109484.CrossRefPubMedPubMedCentral Perera G, Khondoker M, Broadbent M, Breen G, Stewart R. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health case register in London. PLoS ONE. 2014;9:e109484.CrossRefPubMedPubMedCentral
37.
go back to reference Sultana J, Chang C-K, Hayes RD, Broadbent M, Stewart R, Corbett A, Ballard C. Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry. 2014;29:1249–54.CrossRefPubMed Sultana J, Chang C-K, Hayes RD, Broadbent M, Stewart R, Corbett A, Ballard C. Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry. 2014;29:1249–54.CrossRefPubMed
38.
go back to reference Patel R, Jayatilleke N, Broadbent M, Chang C-K, Foskett N, Gorrell G, Hayes RD, Jackson R, Johnston C, Shetty H, Roberts A, McGuire P, Stewart R. Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method. BMJ Open. 2015;5:e007619.CrossRefPubMedPubMedCentral Patel R, Jayatilleke N, Broadbent M, Chang C-K, Foskett N, Gorrell G, Hayes RD, Jackson R, Johnston C, Shetty H, Roberts A, McGuire P, Stewart R. Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method. BMJ Open. 2015;5:e007619.CrossRefPubMedPubMedCentral
39.
go back to reference Religa D, Fereshtehnejad S-M, Cermakova P, Edlund A-K, Garcia Ptacek S, Granqvist N, Hallbäck A, Kåwe K, Farahmand B, Kilander L, Mattsson U-B, Nägga K, Nordström P, Wijk H, Wimo A, Winblad B, Eriksdotter M. SveDem, the Swedish Dementia Registry – a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS ONE. 2015;10(2):e0116538. doi:10.1371/journal.pone.0116538. eCollection 2015.CrossRefPubMedPubMedCentral Religa D, Fereshtehnejad S-M, Cermakova P, Edlund A-K, Garcia Ptacek S, Granqvist N, Hallbäck A, Kåwe K, Farahmand B, Kilander L, Mattsson U-B, Nägga K, Nordström P, Wijk H, Wimo A, Winblad B, Eriksdotter M. SveDem, the Swedish Dementia Registry – a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS ONE. 2015;10(2):e0116538. doi:10.​1371/​journal.​pone.​0116538. eCollection 2015.CrossRefPubMedPubMedCentral
40.
go back to reference Cermakova P, Lund LH, Fereshtehnejad S-M, Johnell K, Winblad B, Dahlström U, Eriksdotter M, Religa D. Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders. Eur J Heart Fail. 2015;17(6):612–9. doi:10.1002/ejhf.222. Cermakova P, Lund LH, Fereshtehnejad S-M, Johnell K, Winblad B, Dahlström U, Eriksdotter M, Religa D. Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders. Eur J Heart Fail. 2015;17(6):612–9.  doi:10.​1002/​ejhf.​222.
41.
go back to reference Skillbäck T, Farahmand BY, Rosén C, Mattsson N, Nägga K, Kilander L, Religa D, Wimo A, Winblad B, Schott JM, Blennow K, Eriksdotter M, Henrik ZH. Cerebrospinal fluid tau and Aβ biomarkers in 5676 dementia patients. Brain. 2015;138:2716–31.CrossRefPubMed Skillbäck T, Farahmand BY, Rosén C, Mattsson N, Nägga K, Kilander L, Religa D, Wimo A, Winblad B, Schott JM, Blennow K, Eriksdotter M, Henrik ZH. Cerebrospinal fluid tau and Aβ biomarkers in 5676 dementia patients. Brain. 2015;138:2716–31.CrossRefPubMed
42.
go back to reference Garcia-Ptacek S, Farahmand B, Kareholt I, Religa D, Cuadrado ML, Eriksdotter M. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry. JAD. 2014;41:467–77.PubMed Garcia-Ptacek S, Farahmand B, Kareholt I, Religa D, Cuadrado ML, Eriksdotter M. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry. JAD. 2014;41:467–77.PubMed
44.
go back to reference Russ TC, Batty GD, Starr JM. Cognitive and behavioural predictors of survival in Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory clinic. Int J Geriatr Psychiatry. 2012;27:844–53.CrossRefPubMed Russ TC, Batty GD, Starr JM. Cognitive and behavioural predictors of survival in Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory clinic. Int J Geriatr Psychiatry. 2012;27:844–53.CrossRefPubMed
45.
go back to reference Russ TC, Parra MA, Lim AE, Law E, Connelly PJ, Starr JM. Prediction of general hospital admission in people with dementia: cohort study. Br J Psychiatry. 2015;206:153–9.CrossRefPubMed Russ TC, Parra MA, Lim AE, Law E, Connelly PJ, Starr JM. Prediction of general hospital admission in people with dementia: cohort study. Br J Psychiatry. 2015;206:153–9.CrossRefPubMed
46.
go back to reference Martyn CN, Pippard EC. Usefulness of mortality data in determining the geography and time trends of dementia. J Epidemiol Community Health. 1988;42:134–7.CrossRefPubMedPubMedCentral Martyn CN, Pippard EC. Usefulness of mortality data in determining the geography and time trends of dementia. J Epidemiol Community Health. 1988;42:134–7.CrossRefPubMedPubMedCentral
Metadata
Title
Big data and data repurposing - using existing data to answer new questions in vascular dementia research
Authors
Fergus N. Doubal
Myzoon Ali
G. David Batty
Andreas Charidimou
Maria Eriksdotter
Martin Hofmann-Apitius
Yun-Hee Kim
Deborah A. Levine
Gillian Mead
Hermann A. M. Mucke
Craig W. Ritchie
Charlotte J. Roberts
Tom C. Russ
Robert Stewart
William Whiteley
Terence J. Quinn
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0841-2

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue